keyboard_arrow_up

Breast Imaging Market Report - Overview, Premium Insights on Imaging Type and Technologies to 2021

This report studies the breast imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities.

Complete report on Breast Imaging Market spread across 150 Pages, Profiling 10 Companies and Supported with 107 Tables and 39 Figures is now available at http://www.rnrmarketresearch.com/breast-imaging-technologies-market-digital-mammography-3d-breast-tomosynthesis-breast-mri-breast-ultrasound-molecular-breast-imaging-optical-imaging-petctpem-modalities-technology-and-marke-market-report.html .

On the basis of type, the global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography.


Global Breast Imaging Market, by Type
  • Ionizing Breast Imaging Technologies
  • Analog Mammography
  • Full-field Digital Mammography (FFDM)
  • 3D Breast Tomosynthesis
  • Positron Emission Tomography/Computed Tomography (PET/CT)
  • Molecular Breast Imaging/Breast-specific Gamma Imaging (MBI/BSGI)
  • Cone-beam Computed Tomography (CBCT)
  • Positron Emission Mammography (PEM)
  • Electric Impedance Tomography
The non-ionizing breast imaging market technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. The automated whole-breast ultrasound (AWBU) segment is expected to grow at the highest CAGR in the next five years, owing to benefits such as high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

Interested in this report, Get sample copy of this research now

http://www.rnrmarketresearch.com/contacts/request-sample?rname=68046 .


The breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global breast imaging market, majorly due to the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses in the region.


The 3D breast tomosynthesis segment is expected to grow at the highest CAGR in the next five years, owing to the increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the key players operating in the global breast imaging market.

Click now for more information on this research of “Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=68046 .


The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, breast imaging market development, market diversification, and competitive assessment) for strengthening their market shares.


Emerging countries, including China and India, are expected to offer significant growth opportunities to market players in the coming years. The growth in these markets will majorly be driven by rising incidence of breast cancer and significant investments by governments and leading players in emerging countries.


On related note another research titled with diagnostic imaging market is estimated to grow at a CAGR of 6.2% from 2015 to 2020. Although the mature market such as North America and Europe hold larger share in diagnostic imaging market, the Asia-Pacific region is expected to grow at the highest CAGR of 7.2% is available at http://www.rnrmarketresearch.com/diagnostic-imaging-market-by-x-ray-systems-digital-analog-portable-computed-tomography-ultrasound-imaging-systems-2d-3d-4d-doppler-mri-machines-closed-open-and-nuclear-imaging-systems-market-report.html .


Explore more reports on Medical Imaging at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/medical-imaging .


About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
RItesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com